James R. Tobin - May 14, 2025 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role: Director
Signature: /s/ Jason Cavalier, Attorney-in-Fact for James R. Tobin
Stock symbol: LYRA
Transactions as of: May 14, 2025
Transactions value $: $0
Form type: 4
Date filed: 5/16/2025, 04:30 PM
Previous filing: Mar 28, 2025
Next filing: May 23, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
TOBIN JAMES R	Director	C/O LYRA THERAPEUTICS, INC., 480 ARSENAL WAY, WATERTOWN	/s/ Jason Cavalier, Attorney-in-Fact for James R. Tobin	2025-05-16	0001190128

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LYRA	Restricted Stock Units	Award	$0	+32K		$0.00	32K	May 14, 2025	Common Stock	32K		Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% on the earlier of (i) the day before the Issuer's next annual meeting, (ii) May 14, 2026 and (iii) upon a Change in Control as defined in the 2020 Incentive Award Plan.